SI2123276T1 - Farmacevtska sestava, vsebujoča derivat pirazina,in postopek z uporabo derivata pirazina v kombinaciji - Google Patents

Farmacevtska sestava, vsebujoča derivat pirazina,in postopek z uporabo derivata pirazina v kombinaciji

Info

Publication number
SI2123276T1
SI2123276T1 SI200830895T SI200830895T SI2123276T1 SI 2123276 T1 SI2123276 T1 SI 2123276T1 SI 200830895 T SI200830895 T SI 200830895T SI 200830895 T SI200830895 T SI 200830895T SI 2123276 T1 SI2123276 T1 SI 2123276T1
Authority
SI
Slovenia
Prior art keywords
pyrazine derivative
combination
pharmaceutical composition
pyrazine
derivative
Prior art date
Application number
SI200830895T
Other languages
English (en)
Inventor
Masako Maekawa
Original Assignee
Toyama Chemical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co., Ltd. filed Critical Toyama Chemical Co., Ltd.
Publication of SI2123276T1 publication Critical patent/SI2123276T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SI200830895T 2007-02-16 2008-02-14 Farmacevtska sestava, vsebujoča derivat pirazina,in postopek z uporabo derivata pirazina v kombinaciji SI2123276T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007035975 2007-02-16
EP08711267A EP2123276B1 (en) 2007-02-16 2008-02-14 Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
PCT/JP2008/052425 WO2008099874A1 (ja) 2007-02-16 2008-02-14 ピラジン誘導体を含有する医薬組成物およびピラジン誘導体を組み合わせて使用する方法

Publications (1)

Publication Number Publication Date
SI2123276T1 true SI2123276T1 (sl) 2013-03-29

Family

ID=39690101

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830895T SI2123276T1 (sl) 2007-02-16 2008-02-14 Farmacevtska sestava, vsebujoča derivat pirazina,in postopek z uporabo derivata pirazina v kombinaciji

Country Status (21)

Country Link
US (1) US8759354B2 (sl)
EP (1) EP2123276B1 (sl)
JP (1) JP5255456B2 (sl)
KR (1) KR101479083B1 (sl)
CN (1) CN101610772B (sl)
AU (1) AU2008215397B2 (sl)
BR (1) BRPI0807597B8 (sl)
CA (1) CA2677905C (sl)
CY (1) CY1113435T1 (sl)
DK (1) DK2123276T3 (sl)
ES (1) ES2396595T3 (sl)
HR (1) HRP20130111T1 (sl)
IL (1) IL200285A (sl)
MX (1) MX2009008779A (sl)
NZ (1) NZ578989A (sl)
PL (1) PL2123276T3 (sl)
PT (1) PT2123276E (sl)
RU (1) RU2463051C2 (sl)
SI (1) SI2123276T1 (sl)
WO (1) WO2008099874A1 (sl)
ZA (1) ZA200905536B (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102388333A (zh) * 2009-04-09 2012-03-21 Lg电子株式会社 显示装置
DK2568976T3 (en) * 2010-05-10 2016-01-11 Academia Sinica Zanamivir-phosphonate congener with the anti-influenza activity, and determining the sensitivity oseltamivir in influenza viruses
MY161429A (en) 2010-09-30 2017-04-14 Toyama Chemical Co Ltd Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide
ES2561878T3 (es) 2010-09-30 2016-03-01 Toyama Chemical Co., Ltd. Sal de meglumina de 6-fluoro-3-hidroxi-2-pirazinacarboxamida
AT510585B1 (de) * 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
CA2911424C (en) * 2013-05-14 2021-11-30 Biocryst Pharmaceuticals, Inc. Anti-influenza imino-ribose pyrrolopyrimidine derivatives
CN104402833B (zh) * 2014-11-20 2016-08-24 广东东阳光药业有限公司 含有环丁烷取代基的吡嗪类化合物及其组合物及用途
CN104447585B (zh) * 2014-11-20 2016-08-24 广东东阳光药业有限公司 吡嗪类化合物及其组合物及用途
CN104447584B (zh) * 2014-11-20 2016-08-24 广东东阳光药业有限公司 含有环丁烷取代基的吡嗪类化合物及其组合物及用途
CN104447583B (zh) * 2014-11-20 2016-08-24 广东东阳光药业有限公司 含有环丁烷取代基的吡嗪类化合物及其组合物及用途
CN104496918B (zh) * 2014-12-10 2016-08-24 广东东阳光药业有限公司 吡嗪衍生物及其用途
CN104817511B (zh) * 2015-04-27 2017-04-19 济南大学 一种丁烯二酸酐制备法匹拉韦关键中间体的方法
RU2745071C2 (ru) * 2015-12-15 2021-03-18 Сионоги Энд Ко., Лтд. Лекарственный препарат для лечения гриппа, характеризующийся тем, что в нем объединены ингибитор кэп-зависимой эндонуклеазы и лекарственное средство против гриппа
EP3903783A4 (en) * 2018-12-25 2022-03-30 FUJIFILM Toyama Chemical Co., Ltd. THERAPEUTIC AGENT FOR RNA VIRAL INFECTION OBTAINED BY COMBINING A PYRAZINE DERIVATIVE AND A COMPOUND THAT INCREASES THE AMOUNT OF PYRAZINE DERIVATIVE RIBOSE TRIPHOSPHATE BODY IN A CELL
JP7449379B2 (ja) 2020-05-27 2024-03-13 富士フイルム富山化学株式会社 ピラジン誘導体とチオプリン誘導体を組み合わせてなるrnaウイルス感染症治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01197437A (ja) * 1988-01-29 1989-08-09 Dso Pharmachim 抗ウイルス薬
AU756635B2 (en) 1998-08-20 2003-01-16 Toyama Chemical Co. Ltd. Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antiviral agents containing both
EP1417967A4 (en) 2001-08-14 2007-03-28 Toyama Chemical Co Ltd NEW VIRUS PROTECTION INHIBITION, VIRCIDIDIC PROCEDURE AND NEW PYRADIN NUCLEOTIDE / PYRADIN NUCLEOSIDE ANALOGON
JP2005354833A (ja) * 2004-06-11 2005-12-22 Fujinon Corp アクチュエータ
JP4689989B2 (ja) * 2004-08-27 2011-06-01 オリンパス株式会社 振動波リニアモータ及びそれを用いたレンズ装置
DE102008031715A1 (de) 2008-07-04 2010-01-07 Henkel Ag & Co. Kgaa Haarkonditionierende Mittel mit Imidazolinen

Also Published As

Publication number Publication date
WO2008099874A1 (ja) 2008-08-21
CN101610772B (zh) 2013-01-16
CA2677905C (en) 2015-03-24
JP5255456B2 (ja) 2013-08-07
RU2463051C2 (ru) 2012-10-10
ES2396595T3 (es) 2013-02-22
KR101479083B1 (ko) 2015-01-07
CY1113435T1 (el) 2016-06-22
US20100087447A1 (en) 2010-04-08
IL200285A (en) 2014-06-30
RU2009134516A (ru) 2011-03-27
BRPI0807597B1 (pt) 2021-03-02
AU2008215397B2 (en) 2012-09-06
US8759354B2 (en) 2014-06-24
HRP20130111T1 (hr) 2013-02-28
DK2123276T3 (da) 2013-01-02
PT2123276E (pt) 2013-01-16
CN101610772A (zh) 2009-12-23
JPWO2008099874A1 (ja) 2010-05-27
EP2123276B1 (en) 2012-11-28
IL200285A0 (en) 2010-04-29
PL2123276T3 (pl) 2013-04-30
MX2009008779A (es) 2009-11-05
NZ578989A (en) 2011-07-29
EP2123276A4 (en) 2011-05-18
BRPI0807597A2 (pt) 2014-05-06
KR20090121289A (ko) 2009-11-25
CA2677905A1 (en) 2008-08-21
ZA200905536B (en) 2010-10-27
BRPI0807597B8 (pt) 2021-05-25
AU2008215397A1 (en) 2008-08-21
EP2123276A1 (en) 2009-11-25

Similar Documents

Publication Publication Date Title
ZA200905536B (en) Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
IL275854A (en) Pharmaceutical composition and its administration
PL1902706T3 (pl) Trwałe w roztworze kompozycje farmaceutyczne tetracyklin, sposób ich otrzymywania i ich zastosowania
HK1117164A1 (en) Dicyclic azaalkane derivatives, preparing method and pharmaceutical use thereof
HK1149268A1 (en) Pyrazine derivatives and their use as protein kinase inhbitors
EP2230241A4 (en) TETRAHYDROIMIDAZOÝ1,5-A¨PYRAZINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND MEDICAL USES THEREOF
ZA201206062B (en) Aminotetraline derivatives,pharmaceutical compositions containing them,and their use in therapy
IL203292A (en) History of n-indazolil affluent, process for preparation, intermediates obtained in this process and pharmacological preparations containing the history
IL200206A (en) The history of quinaxaline, their preparation and their pharmaceutical preparations
IL206594A (en) The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations
IL213570A (en) History 8 - Alkoxy - s - Triazolo [5,1 - a] pyridine and pharmaceutical preparations containing them
AP2590A (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
EP2211851A4 (en) LAMININS, DERIVATIVES, COMPOSITIONS CONTAINING SAME, AND METHOD FOR THEIR THERAPEUTIC USE
EP2345416A4 (en) PHARMACEUTICAL COMPOSITION FOR CLEANING VENES AND MANUFACTURING METHOD THEREFOR
HK1143590A1 (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics 7--18-
EP2322505A4 (en) 1-ADAMANTYLAZETIDIN-2-ON DERIVATIVE, PREPARATION THEREOF AND PHARMACEUTICAL PREPARATION THEREWITH
EP2279999A4 (en) RETINOID DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
HK1152038A1 (en) Azetidine derivatives, their preparation and their application in therapy
IL207298A (en) A derivative of benzenesulfonamide, pharmaceutical preparations containing it and its uses
HK1155062A1 (en) Pharmaceutical composition and combined agent
EP2348019A4 (en) 1,2-DIAZETTIDIN-3-ONE DERIVATIVE AND PHARMACEUTICAL AGENT COMPRISING SAME
IL215551A (en) An indolite derivative, a pharmaceutical preparation containing it and its uses
HK1144093A1 (en) Sophocarpine-series derivative, and preparation method and use thereof
EP2484675A4 (en) NEW PHENYLPYRIDINE DERIVATIVE AND MEDICAMENT THEREOF